Addiction Audio

In this episode, Dr Tsen Vei Lim talks to Dr Katie East, an Associate Professor in Public Health within the Department of Primary Care and Public Health at Brighton and Sussex Medical School in the UK. The interview covers her and her co-authors research report on a randomised online experiment evaluating the impact of vaping fact films on vaping harm perceptions among UK young adults, as well as...

In this episode, Dr Zoe Swithenbank speaks to Dr June Leung, a senior researcher at the SHORE and Whariki Research Centre at Massey University in New Zealand. The interview covers June’s systematic review and meta-analysis on the association of parental or caregiver alcohol use with child maltreatment. ·      An overview of the review and the definition and forms of c...

In this episode, Dr Tsen Vei Lim talks to Dr Lavinia Baltes, Head of Research at the Clinic for Psychiatry and Psychotherapy, Psychiatric Services Aargau, Switzerland. The interview covers her research report on a randomised control trial of public health-oriented recreational cannabis access compared to illegal market access in Basel-Stadt, Switzerland. ·      The cu...

In this episode, Dr Tsen Vei Lim talks to Dr Danilo Romero, a licensed clinical psychologist at the Stockholm Centre for Dependency Disorders in Sweden. The interview covers his research report on the questionable generalisability of the Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) when used as an outcome measure in clinical trials than as a primary care screening tool, highli...

In this episode, Dr Tsen Vei Lim talks to: Dr Marilyn Piccirillo from the Department of Psychiatry at Rutgers University-New Brunswick and Drs Katherine Walukevich-Dienst and Elizabeth Lehinger from the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine. The interview covers their research report on the longer-term efficacy of brief, alcohol-focused...

In this episode, Dr Tsen Vei Lim speaks to Dr Emma Beard, a lecturer in statistics and quantitative methods at University College London. The interview covers Emma’s research report titled, ‘How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?’ ·      How we normally estimate the smoking prevalenc...

In this episode, Dr Elle Wadsworth speaks to Professor Joanne Neale from the Addictions Department at King’s College London and Professor Brian Kelly from the Department of Sociology at Indiana University. The interview covers their editorial titled, ‘Over a decade later and Addiction journal is still committed to publishing qualitative research’.   ·      The or...

In this episode, Dr Tsen Vei Lim talks to Dr James MacKillop, a clinical psychologist and professor at McMaster University in Canada, and director for both the Peter Boris Centre for Addictions Research and the Michael G DeGroote Centre for Medicinal Cannabis Research. The interview covers his research report on the diagnostic validity of drinking behaviour for identifying alcohol use disorder (AU...

In this episode, Dr Elle Wadsworth speaks to Dr Sandra Jumbe from the School of Social and Health Sciences at Millenium University in Malawi and the Wolfson Institute of Public Health Queen Mary, and Dr Chris Newby from the Medical School at the University of Nottingham. Sandra and Chris discuss their findings from a systematic review and meta-analysis on factors associated with adolescent substan...

In this episode, Dr Elle Wadsworth talks to Dr Richard Bade from Queensland Alliance for Environmental Health Sciences at the University of Queensland about his and his co-authors research report on the identification of nitazenes through wastewater analysis, using two-years of data from 22 countries. Richard discusses why a study detecting nitazenes in wastewater was needed and what the future fo...

In this episode, Dr Elle Wadsworth talks to three generations of tobacco/nicotine researchers: Dr Sarah Jackson and Emeritus Professors Martin Jarvis and Robert West, all from the Department of Behavioural Science and Health at University College London. They discuss a recent editorial, ‘The price of a cigarette: 20 minutes of life?’ – why the message resonated, what was and is difficult to convey...

In this episode, Dr Elle Wadsworth talks to Dr Noa Krawczyk from the Department of Population Health at NYU Grossman School of Medicine about her and her co-authors research report on self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities. Noa discusses the current treatments available for opioid use disorder and why psych...

In this episode, Dr Elle Wadsworth talks to Dr James Nicholls from the University of Stirling about an opinion paper he co-authored with Professor Geoffrey Hunt on whether pleasure should receive more attention in public health-oriented alcohol research. They discuss what alcohol researchers and public health professionals can learn about ‘intoxication and pleasure’ from drug research, the differe...

In this episode Dr Elle Wadsworth talks to Professor David Hammond about vaping. They discuss policy differences between the Canada, the UK and the US as well as changes relating to disposable vapes and the use of nicotine salts. They cover the environmental impact of some of these products before talking about the different choices available to policymakers when developing regulations.  “Wha...

In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-authored by Dr Hamina in which the team matched large national datasets to identify excess mortality among people who use drugs that can be attributed to cancers. They found increases in incidences and...

In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about using Avon Longitudinal Study of Parents and Children ( ALSPAC ) data - also known as 'Children of the Nineties' and discusses why psychosis and cannabis potency are important to measure and some of...

In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same period. The research focused on four specific time points, measuring cannabis prevalence against US policy changes. Dr Wadsworth and Professor Caulkins then talk about differences between cannabis and alc...

In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discusses using a cluster randomised trial to compare outcomes in different neighbourhoods (those where the van did and didn't go) and to explore whether the van was effective at improving health outcomes...

In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fat and note the importance of the findings for people who struggle to quit smoking. Germán talks about using Mendelian randomisation to identify a causal association between smoking and abdominal obesi...

In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages ( 2023 ). They discuss the complexities of providing treatment for people who use, and are prescribed, opiates, opiate agonist medications and benzodiazepines. They talk about using a combination of medical and non-m...

In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment settings. They also talk about how contingency management can be used for stimulant use disorders; an area where there are relatively few evidence-based treatments. the team goes on to discuss implementati...

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entered the US drug market but has been increasingly identified in Europe and the UK, even being identified in vapes sold as containing tetrahydrocannabinol (THC). Caroline covers the harms from xylazine an...

In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss organised crime and its impact on cocaine production, drug availability and the potential for drug contamination. They also cover fentanyl and the potential for a heroin drought resulting from changes in...

In this episode Dr Merve Mollaahmetoglu talks to Dr Molly Bowdring about her recent article on the impact of alcohol-free drinks such as zero-percent beers, wines and mocktails. Molly talks about using survey data to explore different patterns, such as using non-alcoholic drinks to slow alcohol consumption, to alternate days or as part of someones recovery. Merve and Molly discuss the occasional d...

In this episode, Rob Calder talks to Dr Philip Newall about how the gambling industry frames the evidence on gambling advertising. Philip talks about researching the kinds of bets that are commonly advertised, explaining how they are often projected to be 'good' bets when the chances of winning are very small. "It's really got the two sides of the coin there in that it appears really attractive, b...